CVS capping purchases of Plan B pills to ensure consistent supply

CVS capping purchases of Plan B pills to ensure consistent supply


Protesters outside the Supreme Court following the overturning of Roe v. Wade.

Brandon Bell | Getty Images News | Getty Images

CVS is limiting the number of the emergency contraceptives commonly known as “morning after pills” and “Plan B” that people can buy on its website and in its stores after last week’s Supreme Court ruling.

The drug store chain said in a statement it had ample supply of the pills online and in stores, but that it wanted to ensure “equitable access and consistent supply on store shelves.” The move comes after the Supreme Court on Friday overturned the landmark ruling that had protected abortion as a constitutional right for nearly 50 years.

CVS Health said it began limiting purchases of Plan B and Aftera, which cost $49.99 and $39.99, respectively, to three per order on Saturday.

Walgreens does not have a purchase limit in place on emergency contraceptives, a representative for the chain said Monday. A representative for Walmart did not immediately respond to a request for comment. The Wall Street Journal reported sales limits on the pills by retailers earlier Monday.

Emergency contraceptive pills are often sold under the Plan B brand and can be purchased over-the-counter and without an ID or prescription. They work by preventing ovulation or preventing a fertilized egg from attaching to the womb and are taken in the days after unprotected sex, or after a contraceptive fails.

The pills are different from medication abortion, or abortion pills, which require a prescription and involve taking two different pills within 10 weeks of pregnancy, according to the Kaiser Family Foundation.

In the days following the Supreme Court’s decision last many, many people took to social media to urge people to stock up on contraceptive pills. Others said potential shortages could impact those most in need and urged people to instead fund organizations that help distribute the pills to keep it available.

–CNBC’s Melissa Repko contributed to this report.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More